GlobeNewsWire
22 Dec 2025, 16:58 UTC · 39w ago
Verdict
Headline takes no side. We score AB +1.00 — strongly bullish.
+1.00strongly bullish
More positive than 98% of ticker scores this week
Which stocks this story touches
More positive than 98% of ticker scores this week
The company was granted a US patent for masitinib in treating sickle cell disease, extending protection until 2040.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−7.9%
Price is moving against the score
$36.19 vs $39.31 close before publication (Dec 19) · not market-adjusted
AB chart →